[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

 Aldesleukin

Product Approval Information - Licensing Action


Proper name: Aldesleukin
Tradename: Proleukin
Manufacturer: Chiron Corp, Emeryville, CA, License #1106
Indication for Use: New indication for use in adults with metastatic melanoma and updated response data for metastatic renal cell carcinoma patients, as well as revised package insert information
Approval Date: 1/9/98
Type of submission: Biologics license supplement


Approval Letter (PDF), (Text)

Reviews (PDF)
    Medical (25 pages)
    Statistical (8 pages)
    Toxicology (18 pages)


Last Updated: 3/5/2001

 

Back to Top     Back to Index

Date created: September 16, 2003

horizonal rule